News | July 17, 2023
Evonik and Heraeus cooperate to expand the range of services for highly potent API
Evonik specializes in mid- to large-scale, later clinical phase HPAPIs
Evonik specializes in mid- to large-scale, later clinical phase HPAPIs
This product will be launched through Granules Consumer Health (GCH) division
India’s bioeconomy jumped from $8 billion in 2014 to $100 billion and the country now targets $150 billion by 2025
Cytel excels at using proven quantitative techniques to transform real-world data into actionable insights
OVAPEX is a unique formula developed by the team of scientists and doctors at Green Milk Concepts
Rare childhood cancer subtype, Ph+ ALL, is found in 3-4% of pediatric cases and 25% of adult cases
The launch of HULIO in the United States is an important milestone for Biocon Biologics
The positive safety review from the DSMB enables the trial to move forward as planned, with an estimated completion date in December 2023
Intent to start at least 5 innovative Phase 3 vaccine programs by 2025
Dr. Reddy's aims to roll out its trade generics across cities and towns in India
Subscribe To Our Newsletter & Stay Updated
